Jump to content
Your browser is out of date. It has known security flaws and may not display all features of this websites. Learn how to update your browser[Close]

Top position threatened

Multinationals fear for Swiss innovation

Multinational companies based in Switzerland, above all those in the chemical, pharmaceutical and biotechnology sectors, see Switzerland’s top position in the international innovation rankings in danger.

 Economiesuisse, the Swiss business federation, is also concerned. Together with the associations Swiss Holdings and Swiss Industries, economiesuisse on Thursday published the results of a study by the University of St Gallen.

 The study, “Research and Innovation Activities of Multinationals in Switzerland”, said the 20 multinationals which spend the most on research generate around 4.7% of gross domestic product (GDP) and create 80,000 jobs in Switzerland.

 Furthermore, the multinationals contribute around 70% of the total investment in research.

 The Basel-based pharma giants Roche and Novartis also belong to the top 20 companies in the world with the largest research budgets.

 The authors say this reinforces the fact that Switzerland’s top position is “directly linked to the innovation strength of the multinationals”.

 “Switzerland submitted 958 patents per million residents in 2014 compared to 224 in the US and 168 in the EU,” said study author Olivier Gassmann.

 He also added that multinationals’ partnership with small and medium-sized enterprises, research and educational institutions and university spin-offs promotes Swiss innovation.

 Initiative threat

 But this position in in jeopardy, according to the study. More and more companies are forced to carry out research and innovation in other countries. Switzerland is no longer just in competition with western countries such as the United States or Germany. Asian countries are increasingly attractive for research. 

Switzerland should therefore look after its research conditions, the authors conclude, seeing a danger in the 2014 mass immigration initiative, in which 50.3% of Swiss agreed with setting limits on the number of EU workers allowed into the country. 

“It is particularly important that when the initiative is implemented, a solution is found that is agreeable for the research and innovation sector,” they said, stressing that the companies must be able to satisfy their need for skilled foreign staff.

swissinfo.ch and agencies


All rights reserved. The content of the website by swissinfo.ch is copyrighted. It is intended for private use only. Any other use of the website content beyond the use stipulated above, particularly the distribution, modification, transmission, storage and copying requires prior written consent of swissinfo.ch. Should you be interested in any such use of the website content, please contact us via contact@swissinfo.ch.

As regards the use for private purposes, it is only permitted to use a hyperlink to specific content, and to place it on your own website or a website of third parties. The swissinfo.ch website content may only be embedded in an ad-free environment without any modifications. Specifically applying to all software, folders, data and their content provided for download by the swissinfo.ch website, a basic, non-exclusive and non-transferable license is granted that is restricted to the one-time downloading and saving of said data on private devices. All other rights remain the property of swissinfo.ch. In particular, any sale or commercial use of these data is prohibited.